{
    "clinical_study": {
        "@rank": "110831", 
        "acronym": "CECA", 
        "arm_group": {
            "arm_group_label": "CECA", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The study \" Autologous cultured corneal epithelium (CECA) for the treatment of unilateral\n      corneal lesions associated with limbal stem cell deficiency\" is the first clinical trial of\n      this product manufactured at the LOEX laboratory. The culture of corneal epithelium strives\n      to produce a reconstructed tissue with the therapeutical aim of treatment of unilateral\n      limbal stem cell deficiency (only one eye is affected by the limbal stem cell deficiency).\n      The study is a phase I/phase II study with the goal to evaluate safety and efficacy of the\n      CECA graft for the treatment of human patients suffering from limbal stem cell deficiency."
        }, 
        "brief_title": "Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Limbal Stem Cell Deficiency", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female patients with limbal stem cell deficiency\n\n        Exclusion Criteria:\n\n          -  Bilateral limbal stem cell deficiency\n\n          -  Unilateral limbal stem cell deficiency with more than 50% of damage to the\n             contralateral eye\n\n          -  Pregnancy\n\n          -  Breast-feeding\n\n          -  Minors\n\n          -  known allergy to aprotinine (Trasylol (R))\n\n          -  Hypersensibility to bovine proteins"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01756365", 
            "org_study_id": "LOEX 015"
        }, 
        "intervention": {
            "arm_group_label": "CECA", 
            "intervention_name": "surgical transplantation of CECA", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Qu\u00e9bec", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "G1S 4L8"
                }, 
                "name": "Centre universitaire d'Ophtalmologie CHU de Qu\u00e9bec - HSS"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "Autologous Cultured Corneal Epithelium ( Culture d'\u00e9pith\u00e9lium corn\u00e9en Autologue CECA) for the Treatment of Unilateral Corneal Lesions Associated With Limbal Stem Cell Deficiency", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Canada: Health Canada"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluation according to the Snellen scale", 
            "measure": "Visual acuity", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01756365"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
            "investigator_full_name": "Richard Bazin", 
            "investigator_title": "Clinical professor ophtalmology, director of the cornea service", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Slit lamp examination: coloration with Fluorescein", 
                "measure": "epithelial deficit", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Slit lamp examination", 
                "measure": "Opacity / transparency of the cornea", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Slit lamp examination", 
                "measure": "peripheral and central vascularization", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Slit lamp examination", 
                "measure": "Integrity of the surface of the epithelium", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}